NCT07003178View on ClinicalTrials.gov

A Study to Evaluate the Safety and Clinical Efficacy of STR-P004

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

May 31, 2027

Conditions
Non Hodgkin Lymphoma
Interventions
DRUG

STR-P004

An in vivo CART drug administered intravenously

Trial Locations (1)

215123

Starna, Suzhou

Sponsors
All Listed Sponsors
lead

Starna Therapeutics

INDUSTRY

NCT07003178 - A Study to Evaluate the Safety and Clinical Efficacy of STR-P004 | Biotech Hunter | Biotech Hunter